Principal Securities, Inc. Procept Bio Robotics Corp Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Principal Securities, Inc. holds 28 shares of PRCT stock, worth $921. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 124
77.42%
Holding current value
$921
Previous $9.98 Million
83.84%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
292Shares Held
44MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$173 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$115 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$71 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$50.3 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$43.5 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.47B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...